• 18717796589
18717796589

证据文献

NO 论文 登载期刊 PM ID 全文链接 中文链接
1 辅助免疫细胞疗法与全身系统性疗法结合治疗实体瘤的疗效 Anticancer Research 42: 4179-4187　/ 2022 35896218 https://ar.iiarjournals.org/content/42/8/4179 http://www.morimt.net/laitian/results/22.html
2 食管癌对免疫细胞疗法和低剂量纳武单抗联合治疗有反应 Journal of Medical Case Reports 15, Article number: 191 / 2021 33827668 https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z http://www.morimt.net/laitian/results/23.html
3 免疫细胞疗法治疗晚期/复发性乳腺癌的预后因素 Anticancer Research 41:4133-4141 / 2021 34281884 https://ar.iiarjournals.org/content/41/8/4133.long http://www.morimt.net/laitian/results/1.html
4 过继性T细胞免疫治疗对晚期胰腺癌患者免疫学指标及预后的影响 CYTOTHERAPYFeb;23(2):137-145/2020 32907781 https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6 http://www.morimt.net/laitian/results/2.html
5 接受一线化疗免疫治疗的转移性结直肠癌患者的免疫状态变化 Anticancer Research 40:4763-4771 / 2020 32727803 https://ar.iiarjournals.org/content/40/8/4763.long http://www.morimt.net/laitian/results/3.html
6 过继免疫细胞治疗子宫颈神经内分泌癌 Anticancer Research 40:4741-4748 / 2020 32727800 https://ar.iiarjournals.org/content/40/8/4763 http://www.morimt.net/laitian/results/4.html
7 免疫细胞治疗子宫内膜癌和宫颈癌预后因素的回顾性研究 Anticancer Research 40:4729-4740 / 2020 32727799 https://ar.iiarjournals.org/content/40/8/4729.long http://www.morimt.net/laitian/results/5.html
8 适应性免疫细胞治疗对晚期胃癌患者免疫细胞谱的影响 Cancer Med 9(14):4907-4917 / 2020 32529780 https://ar.iiarjournals.org/content/40/8/4729.long http://www.morimt.net/laitian/results/6.html
9 γδT细胞免疫治疗实体瘤预后因素的研究 CYTOTHERAPY Jun;22(6):329-336 / 2020 32303429 https://pubmed.ncbi.nlm.nih.gov/32303429/ http://www.morimt.net/laitian/results/7.html
10 免疫细胞联合一线化疗治疗结直肠癌的预后因素：一项回顾性研究 Anticancer Research 39: 4525-4532 / 2019 31366555 https://pubmed.ncbi.nlm.nih.gov/31366555/ http://www.morimt.net/laitian/results/8.html
11 免疫细胞治疗胰腺癌患者的预后因素 Anticancer Research 38 (7) 4353-4360 / 2018 29970573 https://pubmed.ncbi.nlm.nih.gov/29970573/ http://www.morimt.net/laitian/results/9.html
12 肿瘤内注射唑来膦酸盐冲击树突状细胞、静脉过继活化T淋巴细胞和吉西他滨联合综合免疫治疗不可切除的局部晚期胰腺癌的I/II期临床研究 Oncotarget Dec5;9(2):2838-2847./2017 29416816 https://pubmed.ncbi.nlm.nih.gov/29416816/ http://www.morimt.net/laitian/results/10.html
13 全身静脉过继转移自体淋巴因子激活的αβT细胞改善替莫唑胺诱导的胶质瘤患者淋巴细胞减少 Anticancer Research Jul;37(7):3921-3932./2017 28668896 https://pubmed.ncbi.nlm.nih.gov/28668896/ http://www.morimt.net/laitian/results/11.html
14 过继免疫联合化疗治疗IV期结直肠癌的临床研究（COMVI研究） Anticancer Research Jul;37(7):3941-3946. / 2017 28668898 https://pubmed.ncbi.nlm.nih.gov/28668898/ http://www.morimt.net/laitian/results/12.html
15 过继免疫细胞疗法治疗晚期胃癌的回顾性研究 Anticancer Research Jul;37(7):3947-3954. / 2017 28668899 https://pubmed.ncbi.nlm.nih.gov/28668899/ http://www.morimt.net/laitian/results/13.html
16 mRNA-EP制备的肿瘤血管靶向CAR-T细胞用于临床研究的免疫学质量和性能 Mol Ther Oncolytics.Nov 16;3:16024. / 2016 27909701 https://pubmed.ncbi.nlm.nih.gov/27909701/ http://www.morimt.net/laitian/results/14.html
17 活化αβT细胞过继免疫化疗治疗IV期结直肠癌 Anticancer Research Jul;36(7):3741-6. / 2016 27354648 https://pubmed.ncbi.nlm.nih.gov/27354648/ http://www.morimt.net/laitian/results/15.html
18 WT1抗原在多种实体癌细胞中表达的免疫组织化学分析 Anticancer Research 36(7):3715-3724 / 2016 27354645 https://pubmed.ncbi.nlm.nih.gov/27354645/ http://www.morimt.net/laitian/results/16.html
19 自体免疫细胞治疗改善不同类型晚期癌症患者的免疫功能受损 Anticancer Research 36(7):3715-3724 / 2016 26168498 https://pubmed.ncbi.nlm.nih.gov/26168498/ http://www.morimt.net/laitian/results/17.html
20 免疫细胞治疗在不同类型晚期癌症患者中的前瞻性安全性评价 Anticancer Research 35(8):4535-4543 / 2015 25075106 https://pubmed.ncbi.nlm.nih.gov/25075106/ http://www.morimt.net/laitian/results/18.html
21 在晚期癌症患者中评估细胞免疫状态受损和失衡，并通过过继性T细胞免疫治疗恢复T细胞免疫状态 International Immunopharmacology18(1):90-97. / 2014 24269583 https://pubmed.ncbi.nlm.nih.gov/24269583/ http://www.morimt.net/laitian/results/19.html
22 封闭流式电穿孔系统治疗实体瘤的自体肿瘤溶解物树突状细胞疫苗免疫治疗 Anticancer Research 33(7):2971-6. / 2013 23780988 https://pubmed.ncbi.nlm.nih.gov/23780988/ http://www.morimt.net/laitian/results/20.html
23 晚期肺癌过继性活化T淋巴细胞免疫治疗中观察到的生存期延长：一项多中心历史性队列研究的结果 Cancer Immunology, Immunotherapy 61:1781-1790. / 2012 22422103 https://pubmed.ncbi.nlm.nih.gov/22422103/ http://www.morimt.net/laitian/results/21.html